Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids

Science

Volumn 339, Issue 6117, 2013, Pages 335-339

  Niwa, Minae ^a,b,c   Jaaro Peled, Hanna ^b   Tankou, Stephanie ^b   Seshadri, Saurav ^b   Hikida, Takatoshi ^b,d   Matsumoto, Yurie ^a,c   Cascella, Nicola G ^b   Kano, Shin Ichi ^b   Ozaki, Norio ^c   Nabeshima, Toshitaka ^a   Sawa, Akira ^b  

^a MEIJO UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST;

ADOLESCENCE; ADULT; BIOCHEMISTRY; BRAIN; CHILD HEALTH; DEVELOPMENTAL STAGE; DNA; ENVIRONMENTAL STRESS; GENETICS; HEALTH RISK; MENTAL HEALTH; MOLECULAR ANALYSIS; NERVOUS SYSTEM DISORDER; NEUROLOGY; PHENOTYPE; RODENT;

ARTICLE; DEPRESSION; DNA METHYLATION; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL STRESS; EPIGENETICS; GENETIC RISK; MENTAL DISEASE; NEUROCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SOCIAL ISOLATION;

EID: 84872443390     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1226931     Document Type: Article

References (23)

1. S. J. Blakemore, Nat. Rev. Neurosci. 9, 267 (2008).
2. A. Caspi, B. W. Roberts, R. L. Shiner, Annu. Rev. Psychol. 56, 453 (2005).
3. M. Gunnar, K. Quevedo, Annu. Rev. Psychol. 58, 145 (2007).
4. M. J. Meaney, Child Dev. 81, 41 (2010).
5. T. E. Moffitt, A. Caspi, M. Rutter, Arch. Gen. Psychiatry 62, 473 (2005).
6. J. van Os, G. Kenis, B. P. Rutten, Nature 468, 203 (2010).
7. E. R. de Kloet, M. Joëls, F. Holsboer, Nat. Rev. Neurosci. 6, 463 (2005).
8. E. R. de Kloet, N. Y. Rots, A. R. Cools, Cell. Mol. Neurobiol. 16, 345 (1996).
9. C. Morgan, M. Charalambides, G. Hutchinson, R. M. Murray, Schizophr. Bull. 36, 655 (2010).
10. M. Niwa, Y. Matsumoto, A. Mouri, N. Ozaki, T. Nabeshima, Int. J. Neuropsychopharmacol. 14, 459 (2011).
11. M. Fleshner et al., Endocrinology 136, 5336 (1995).
12. D. Saal, Y. Dong, A. Bonci, R. C. Malenka, Neuron 37, 577 (2003).
13. T. Hagerty et al., J. Neurochem. 78, 1379 (2001).
14. R. S. Lee et al., Psychopharmacology 218, 303 (2011).
15. Y. Ago et al., Neuropharmacology 55, 1355 (2008).
16. S. Lammel et al., Neuron 57, 760 (2008).
17. R. Adolphs, Nat. Rev. Neurosci. 4, 165 (2003).
18. R. M. Murray, P. D. Morrison, C. Henquet, M. Di Forti, Nat. Rev. Neurosci. 8, 885 (2007).
19. M. Popoli, Z. Yan, B. S. McEwen, G. Sanacora, Nat. Rev. Neurosci. 13, 22 (2012).
20. N. J. Brandon, A. Sawa, Nat. Rev. Neurosci. 12, 707 (2011).
21. M. M. Ohayon, A. F. Schatzberg, Am. J. Psychiatry 159, 1855 (2002).
22. W. Coryell, B. Pfohl, M. Zimmerman, J. Nerv. Ment. Dis. 172, 521 (1984).
23. B. H. Flores, H. Kenna, J. Keller, H. B. Solvason, A. F. Schatzberg, Neuropsychopharmacology 31, 628 (2006).